{
  "actions": [
    {
      "acted_at": "2003-06-24",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2003-06-24",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2003-06-24",
      "action_code": "H11100",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2003-07-01",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    },
    {
      "acted_at": "2003-07-02",
      "action_code": "",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Trade.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr2577-108",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM",
      "subcommittee": "Subcommittee on Trade",
      "subcommittee_id": "04"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "108",
  "cosponsors": [
    {
      "bioguide_id": "B001250",
      "district": "1",
      "name": "Bishop, Rob",
      "original_cosponsor": true,
      "sponsored_at": "2003-06-24",
      "state": "UT",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "B000617",
      "district": "23",
      "name": "Bonilla, Henry",
      "original_cosponsor": false,
      "sponsored_at": "2003-09-17",
      "state": "TX",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "C001051",
      "district": "31",
      "name": "Carter, John R.",
      "original_cosponsor": false,
      "sponsored_at": "2003-07-09",
      "state": "TX",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2003-06-24",
  "number": "2577",
  "official_title": "To require the Comptroller General to conduct a study and submit to Congress a report on price controls of foreign governments on pharmaceuticals.",
  "popular_title": null,
  "related_bills": [],
  "short_title": null,
  "sponsor": {
    "bioguide_id": "B001248",
    "district": "26",
    "name": "Burgess, Michael C.",
    "state": "TX",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2003-06-24",
  "subjects": [
    "Commerce",
    "Congress",
    "Congressional investigations",
    "Congressional reporting requirements",
    "Drug industry",
    "Drugs",
    "Economics and Public Finance",
    "Foreign trade and international finance",
    "Health",
    "International Affairs",
    "Nontariff trade barriers",
    "Prescription pricing",
    "Price regulation",
    "Trade negotiations"
  ],
  "subjects_top_term": "Foreign trade and international finance",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2003-06-24",
    "date": "2004-03-03T20:57:43Z",
    "text": "Requires the Comptroller General to conduct a study and report to Congress on: (1) the impact of price controls on pharmaceuticals by foreign governments, including the impact on market access for U.S. pharmaceuticals and on pharmaceutical prices for U.S. consumers; and (2) the extent to which negotiations conducted by the U.S. Trade Representative under the Bipartisan Trade Promotion Authority Act of 2002 facilitate the elimination of such price controls."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To require the Comptroller General to conduct a study and submit to Congress a report on price controls of foreign governments on pharmaceuticals.",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To require the Comptroller General to conduct a study and submit to Congress a report on price controls of foreign governments on pharmaceuticals.",
      "type": "official"
    }
  ],
  "updated_at": "2023-01-15T16:33:41Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/108/hr/BILLSTATUS-108hr2577.xml"
}